A detailed history of Lord, Abbett & Co. LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 238,205 shares of NUVL stock, worth $21.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
238,205
Previous 452,192 47.32%
Holding current value
$21.3 Million
Previous $34 Million 46.78%
% of portfolio
0.06%
Previous 0.11%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 07, 2024

SELL
$62.76 - $81.61 $13.4 Million - $17.5 Million
-213,987 Reduced 47.32%
238,205 $18.1 Million
Q2 2024

Aug 14, 2024

SELL
$62.76 - $81.61 $13.4 Million - $17.5 Million
-213,987 Reduced 47.32%
238,205 $18.1 Million
Q1 2024

Oct 07, 2024

SELL
$72.35 - $88.99 $141,733 - $174,331
-1,959 Reduced 0.43%
452,192 $34 Million
Q1 2024

May 09, 2024

SELL
$72.35 - $88.99 $141,733 - $174,331
-1,959 Reduced 0.43%
452,192 $34 Million
Q4 2023

Oct 07, 2024

BUY
$42.42 - $80.28 $9.16 Million - $17.3 Million
215,946 Added 90.66%
454,151 $33.4 Million
Q4 2023

Feb 12, 2024

BUY
$42.42 - $80.28 $19.3 Million - $36.5 Million
454,151 New
454,151 $33.4 Million

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.83B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.